朱婷婷, 宣铭杨, 饶向荣. 慢性肾脏病合并心力衰竭患者的防治[J]. 临床肾脏病杂志, 2023, 23(4): 333-339. DOI: 10.3969/j.issn.1671-2390.2023.04.009
    引用本文: 朱婷婷, 宣铭杨, 饶向荣. 慢性肾脏病合并心力衰竭患者的防治[J]. 临床肾脏病杂志, 2023, 23(4): 333-339. DOI: 10.3969/j.issn.1671-2390.2023.04.009
    Zhu Ting-ting, Xuan Ming-yang, Rao Xiang-rong. Management of patients with chronic kidney disease plus heart failure[J]. Journal of Clinical Nephrology, 2023, 23(4): 333-339. DOI: 10.3969/j.issn.1671-2390.2023.04.009
    Citation: Zhu Ting-ting, Xuan Ming-yang, Rao Xiang-rong. Management of patients with chronic kidney disease plus heart failure[J]. Journal of Clinical Nephrology, 2023, 23(4): 333-339. DOI: 10.3969/j.issn.1671-2390.2023.04.009

    慢性肾脏病合并心力衰竭患者的防治

    Management of patients with chronic kidney disease plus heart failure

    • 摘要: 慢性肾脏病患心血管疾病风险增加,主要表现为心力衰竭。慢性肾脏病合并心衰十分常见,且常伴不良预后。慢性肾脏病独特的病理生理机制可能是慢性肾脏病合并心力衰竭患者与单纯心血管疾病患者病死率差距较大的原因。目前心力衰竭患者的治疗已经建立了强有力的证据,而慢性肾脏病合并心力衰竭患者的治疗尚无基于高水平的临床证据的指南推荐。本文总结归纳慢性肾脏病合并心力衰竭的诊断和治疗思路,为慢性肾脏病合并心力衰竭的防治提供一些参考。

       

      Abstract: Chronic kidney disease (CKD) is associated with an elevated risk of cardiovascular disease, particularly in the form of heart failure (HF). HF with concurrent CKD is quite common and it is associated frequently with a poor prognosis. The unique pathophysiological mechanisms of CKD may explain a large difference in mortality between patients with CKD plus HF and those with cardiovascular disease alone. While strong evidence has been established for managing HF patients, no guideline recommendation based upon a high level of clinical evidence is available for dealing with patients with CKD plus HF. This review summarized the diagnostic and therapeutic rationales for managing CKD plus HF.

       

    /

    返回文章
    返回